Sartorius shares rise after report of Elliott investment

Bio-Rad Laboratories

18/05/2026 08:37

** Shares in Sartorius SATG_p.DE are up 2% after the Wall Street Journal reported that activist investor Elliott Investment Management had built a stake in the biopharma equipment supplier

** Elliott is also reported to have built a "significant" stake in Bio-Raad Laboratories, which UBS says owns 28% of Sartorius

** The WSJ said Elliott is planning to push Bio-Rad to improve its underperforming stock price and unlock value from Sartorius

** Elliott believes Sartorius is a high-quality business with strong growth prospects, WSJ said

** Sartorius sits atop the German midcap index .MDAXI, which is down 1.2%

** Shares in subsidiary Sartorius Stedim Biotech STDM.PA up 0.5%, above the wider SPF 120 Index .SBF120, which is down 1.1%

 (Reporting by Bernadette Hogg)

 ((bernadette.hogg@thomsonreuters.com))